Clinical Trials

Clinical Trials

Anemia and Chronic Kidney Disease Clinical Trial

Trial summary   

This research study is evaluating the ability of an investigational medication to increase hemoglobin levels in patients with chronic kidney disease. The investigational medication, called Vadadustat, is an oral pill compared to the currently available and approved injectable treatments for anemia. There will be office visits every two weeks during the first three months of the study, then monthly and quarterly thereafter.

Key inclusion criteria

  • Chronic kidney disease, not on dialysis
  • Low hemoglobin levels (anemia)
  • No active cancer, bone marrow disease or active bleeding problems

Compensation for time and travel

Our research patients are closely monitored by our cardiologists, nurses and research team. The study medication and all study-related procedures and physical exams are provided at no cost. You will be reimbursed $52 for each study visit; valet parking is provided at no cost.

About anemia and chronic kidney disease

The kidneys play an important role in maintaining the level of hemoglobin in the blood. Declining kidney function may sometimes affect and lower the level of hemoglobin in the body, which may cause some individuals to become tired and short of breath. Sometimes individuals may need to take medication to help increase their levels of hemoglobin.

Click the button below to complete the Clinical Trials Interest Form, or call 651-326-4448 for more information.

Get started